BioElectronics Corporation
BIEL
$0.0001
-$0.0001-50.00%
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | -670.09% | 148.70% | 66.81% | -27.51% | 67.46% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 289.25% | -253.49% | -24.80% | -37.37% | 0.07% |
| Change in Net Operating Assets | 92.17% | -84.26% | 83.80% | -29.59% | -172.22% |
| Cash from Operations | 146.28% | -1,391.30% | 96.12% | -113.49% | -1,223.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 268.60% | -66.67% | -15.49% | -42.74% | 588.89% |
| Total Debt Repaid | -5,562.86% | 66.67% | 58.82% | -396.51% | 120.38% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -267.66% | 200.00% | -- | -- | -- |
| Cash from Financing | -211.27% | 56.91% | -52.37% | -18.67% | 6,575.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -167.66% | -137.24% | 173.89% | -212.81% | 496.06% |
